Stockscreener 앱 받기
1.42
18.86%
-0.33
시간 외 거래:
1.40
-0.02
-1.41%
전일 마감가:
$1.75
열려 있는:
$1.5
하루 거래량:
716.23K
Relative Volume:
0.84
시가총액:
$33.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.58%
1개월 성능:
+19.33%
6개월 성능:
-21.98%
1년 성능:
+0.00%
1일 변동 폭
$1.42
$1.64
1주일 범위
$1.36
$2.18
52주 변동 폭
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
명칭
Rein Therapeutics Inc
전화
(737) 802-1989
주소
12407 N. MOPAC EXPY., AUSTIN
RNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.42 | 42.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2017-07-24 | 개시 | BofA/Merrill | Buy |
| 2017-07-24 | 개시 | Jefferies | Buy |
| 2017-07-24 | 개시 | William Blair | Outperform |
Rein Therapeutics Inc 주식(RNTX)의 최신 뉴스
Price momentum metrics for Rein Therapeutics Inc. explainedWeekly Volume Report & Low Risk Entry Point Tips - newser.com
How Rein Therapeutics Inc. stock reacts to bond yieldsJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
Comparing Rein Therapeutics Inc. in custom built stock radars2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Will Rein Therapeutics Inc. stock maintain momentum in 20252025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
Ranking Rein Therapeutics Inc. among high performing stocks via toolsSell Signal & AI Enhanced Trading Signals - newser.com
Rein Therapeutics Inc. stock retracement – recovery analysisQuarterly Trade Report & Precise Swing Trade Alerts - newser.com
Rein Therapeutics Inc. (RNTX) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why retail investors pile into Rein Therapeutics Inc. stockQuarterly Growth Report & Capital Efficient Trade Techniques - newser.com
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - MarketScreener
Brookline Capital Markets upgrades Rein Therapeutics stock rating to Buy By Investing.com - Investing.com Canada
RNTX Jolted: Analyzing Stock Movement - StocksToTrade
Why Is Rein Therapeutics Stock Trading Higher On Monday? - Benzinga
Technical signs of recovery in Rein Therapeutics Inc.July 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com
Rein Therapeutics Receives FDA Clearance to Resume Phase 2 Trial - TradingView
News impact scoring models applied to Rein Therapeutics Inc.Weekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Using economic indicators to assess Rein Therapeutics Inc. potentialWeekly Stock Report & Safe Swing Trade Setups - newser.com
Multi asset correlation models including Rein Therapeutics Inc.Weekly Trend Summary & Daily Growth Stock Tips - newser.com
Why Rein Therapeutics Inc. stock attracts high net worth investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Will Rein Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Rein Therapeutics Inc. Stock (RNTX) Opinions on Institutional Investments and Funding Deals - Quiver Quantitative
Rein Therapeutics Inc (RNTX) 재무 분석
Rein Therapeutics Inc (RNTX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):